These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 854075

  • 1. Bone marrow delta-aminolevulinic acid synthetase activity in hematological disorders.
    Tanaka M.
    Nagoya J Med Sci; 1977 Jan; 39(1-2):21-31. PubMed ID: 854075
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. delta-Aminolevulinic acid synthetase in erythroblasts of patients with pyridoxine-responsive anemia. Hypercatabolism caused by the increased susceptibility to the controlling protease.
    Aoki Y, Muranaka S, Nakabayashi K, Ueda Y.
    J Clin Invest; 1979 Nov; 64(5):1196-203. PubMed ID: 500806
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Bone marrow delta-aminolevulinic acid synthetase activity in experimental sideroblastic anemia.
    Tanaka M, Bottomley SS.
    J Lab Clin Med; 1974 Jul; 84(1):92-8. PubMed ID: 4833846
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [A case of acquired sideroblastic anemia with reduced activity of either delta-aminolevulinic acid synthetase in erythroblasts or neutral protease and cytochrome oxidase in granulocytes (author's transl)].
    Murosaki S, Ichikawa Y, Nagao T, Arimori S.
    Rinsho Ketsueki; 1978 Aug; 19(8):1063-9. PubMed ID: 213624
    [No Abstract] [Full Text] [Related]

  • 8. Aminolevulinic acid synthetase activity in erythroblasts of patients with primary sideroblastic anemia.
    Aoki Y, Urata G, Takaku F.
    Nihon Ketsueki Gakkai Zasshi; 1973 Feb; 36(1):74-7. PubMed ID: 4738994
    [No Abstract] [Full Text] [Related]

  • 9. [Delta-aminolevulinic acid synthetase activity in erythroblasts of patients with various hematological disorders (author's transl)].
    Takaku F, Aoki Y, Urata G.
    Rinsho Ketsueki; 1973 Dec; 14(0):1303-10. PubMed ID: 4807604
    [No Abstract] [Full Text] [Related]

  • 10. A case of primary acquired sideroblastic anemia with deficient -aminolevulinic acid synthetase activity in bone marrow erythroblasts.
    Tanaka M, Ota H.
    Tohoku J Exp Med; 1972 Feb; 106(2):199-206. PubMed ID: 5027484
    [No Abstract] [Full Text] [Related]

  • 11. Measurement of delta-aminolevulinic acid synthetase activity in human erythroblasts.
    Aoki Y, Urata G, Wada O, Takaku F.
    J Clin Invest; 1974 May; 53(5):1326-34. PubMed ID: 4825227
    [Abstract] [Full Text] [Related]

  • 12. Delta-aminolevulinic acid synthetase activity in normal human bone marrow and in patients with idiopathic sideroblastic anemia.
    Bottomley SS, Tanaka M, Self J.
    Enzyme; 1973 May; 16(1):138-45. PubMed ID: 4208577
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Sideroblastic anaemia.
    Bottomley SS.
    Clin Haematol; 1982 Jun; 11(2):389-409. PubMed ID: 7042158
    [No Abstract] [Full Text] [Related]

  • 15. Sideroblasts, siderocytes, and sideroblastic anemia.
    Cartwright GE, Deiss A.
    N Engl J Med; 1975 Jan 23; 292(4):185-93. PubMed ID: 1088923
    [No Abstract] [Full Text] [Related]

  • 16. Multiple mechanisms for hereditary sideroblastic anemia.
    Furuyama K, Sassa S.
    Cell Mol Biol (Noisy-le-grand); 2002 Feb 23; 48(1):5-10. PubMed ID: 11929048
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.